Ratings Ramsay Health Care Limited

Equities

RHC

AU000000RHC8

Market Closed - Australian S.E. Other stock markets 11:40:42 02/05/2024 am IST			5-day change	1st Jan Change
50.98 ^AUD	-0.20%		-3.04%	-3.10%

23/04	Wesfarmers Reportedly Runs the Ruler over Ramsay Health Care	CI
29/03	JPMorgan Downgrades Ramsay Health Care to Underweight from Neutral; Price Target is AU$50	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

Over the last twelve months, the sales forecast has been frequently revised upwards.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

Weaknesses

The company does not generate enough profits, which is an alarming weak point.
The group shows a rather high level of debt in proportion to its EBITDA.
The firm trades with high earnings multiples: 19.64 times its 2024 earnings per share.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	ESG Refinitiv
RAMSAY HEALTH CARE LIMITED	-3.10%	7.59B	A-
AIER EYE HOSPITAL GROUP CO., LTD.	-18.46%	16.57B	B+
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.43B	B
IHH HEALTHCARE	+4.98%	11.69B	B+
APOLLO HOSPITALS ENTERPRISE LIMITED	+4.46%	10.24B	B+
ENCOMPASS HEALTH CORPORATION	+24.81%	8.3B	B
MOUWASAT MEDICAL SERVICES COMPANY	+20.21%	7.15B	D
THE ENSIGN GROUP, INC.	+3.85%	6.8B	B-
GLOBAL HEALTH LIMITED	+50.68%	4.65B	-
DALLAH HEALTHCARE COMPANY	-5.12%	4.22B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes